Hans K Hasselbalch
Clinical Professor
Department of Clinical Medicine
Køgevej 7 - 13, 4000 Roskilde
Member of:
Internal Medicine: Haematology
- Published
Pronounced gut microbiota signatures in patients with JAK2V617F-positive essential thrombocythemia
Eickhardt-Dalbøge, C. S., Ingham, A. C., Nielsen, H. V., Fuursted, K., Stensvold, C. R., Andersen, L. O., Larsen, Morten Kranker, Kjær, L., Christensen, S. F., Knudsen, T. A., Skov, V., Ellervik, Christina, Olsen, L. R., Hasselbalch, Hans Carl, Elmer Christensen, J. J. & Nielsen, X. C., 2023, In: Microbiology Spectrum. 11, 5, 19 p., e0066223.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
JAK2V617F drives gut microbiota differences in patients with myeloproliferative neoplasms
Eickhardt-Dalbøge, C. S., Nielsen, H. V., Fuursted, K., Stensvold, C. R., Andersen, L. O., Lilje, B., Larsen, Morten Kranker, Kjær, L., Christensen, S. F., Knudsen, T. A., Skov, V., Sørensen, A. L., Ellervik, Christina, Olsen, L. R., Christensen, J. J. E., Nielsen, X. C., Hasselbalch, Hans Carl & Ingham, A. C., 2024, In: European Journal of Haematology. 112, 5, p. 776-787 12 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
The gut microbiota in patients with polycythemia vera is distinct from that of healthy controls and varies by treatment
Eickhardt-dalbøge, C. S., Ingham, A. C., Andersen, L. O., Nielsen, H. V., Fuursted, K., Stensvold, C. R., Larsen, M. K., Kjær, L., Christensen, S. F., Knudsen, T. A., Skov, V., Ellervik, C., Olsen, L. R., Hasselbalch, Hans Carl, Nielsen, X. C. & Christensen, J. J. E., 2023, In: Blood advances. 7, 13, p. 3326-3337 12 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Chronic inflammation and autoimmunity as risk factors for the development of chronic myelomonocytic leukemia?
Elbæk, M. V., Sørensen, A. L. & Hasselbalch, Hans Carl, 2 Aug 2016, In: Leukemia and Lymphoma. 57, 8, p. 1793-1799 7 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Cardiovascular disease in chronic myelomonocytic leukemia: do monocytosis and chronic inflammation predispose to accelerated atherosclerosis?
Elbæk, M. V., Sørensen, A. L. & Hasselbalch, Hans Carl, 2019, In: Annals of Hematology. 98, 1, p. 101-109Research output: Contribution to journal › Journal article › Research › peer-review
- Published
A retrospective analysis of the impact of treatments and blood counts on survival and the risk of vascular events during the course of polycythaemia vera
Enblom-Larsson, A., Girodon, F., Bak, M., Hersby, D., Jooste, V., Hasselbalch, Hans Carl, Johansson, P. & Andreasson, B., 2017, In: British Journal of Haematology. 177, 5, p. 800-805Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Response to pegylated interferon in a COVID-19–positive elderly woman with primary myelofibrosis treated with ruxolitinib
Frankel, A. E., Reddy, R., DeSuza, K. R., Deeb, K., Carlin, A. F., Smith, D., Xie, Y., Naik, E., Silver, R. T. & Hasselbalch, Hans Carl, 2021, In: Clinical Case Reports. 9, 4, p. 2228-2235 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Response to pegylated interferon in a COVID-19 positive male with metastatic jejunal neuroendocrine tumor treated with everolimus
Frankel, A. E., Yip, W. C., Naik, E. & Hasselbalch, Hans Carl, 2021, In: Clinical Case Reports. 9, 6, e04218.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Chronic myeloproliferative neoplasms and subsequent cancer risk: A Danish population-based cohort study
Frederiksen, H., Farkas, D. K., Christiansen, C. F., Sørensen, H. T. & Hasselbalch, Hans Carl, 15 Dec 2011, In: Blood. 118, 25, p. 6515-6520 6 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Vascular diseases in patients with chronic myeloproliferative neoplasms: Impact of comorbidity
Frederiksen, H., Szépligeti, S., Bak, M., Ghanima, W., Hasselbalch, Hans Carl & Christiansen, C. F., 2019, In: Clinical Epidemiology. 2019, 11, p. 955-967Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Effect of thrombopoietin receptor agonists on markers of coagulation and P-selectin in patients with immune thrombocytopenia
Garabet, L., Ghanima, W., Monceyron Jonassen, C., Skov, V., Holst, R., Mowinckel, M., Hasselbalch, Hans Carl, A. Kruse, T., Thomassen, M., Liebman, H., Bussel, J. B. & Sandset, P. M., 2019, In: Platelets. 30, 2, p. 206-212Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Fibroproliferative activity in patients with immune thrombocytopenia (ITP) treated with thrombopoietic agents
Ghanima, W., Bussel, J. B., Junker, P., Hasselbalch, Hans Carl, Gudbrandsdottir, S., Boiocchi, L., Geyer, J. T., Orazi, A. & Feng, X., 1 Oct 2011, In: British Journal of Haematology. 155, 2, p. 248-255 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Calreticulin mutant myeloproliferative neoplasms induce MHC-I skewing, which can be overcome by an optimized peptide cancer vaccine
Gigoux, M., Holmström, M. O., Zappasodi, R., Park, J. J., Pourpe, S., Bozkus, C. C., Mangarin, L. M. B., Redmond, D., Verma, S., Schad, S., George, M. M., Venkatesh, D., Ghosh, A., Hoyos, D., Molvi, Z., Kamaz, B., Marneth, A. E., Duke, W., Leventhal, M. J., Jan, M. & 23 others, , 2022, In: Science Translational Medicine. 14, 649, eaba4380.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Event-free survival in patients with polycythemia vera treated with ropeginterferon alfa-2b versus best available treatment
the PROUD-PV Study Group, T. P. S. G., 2023, In: Leukemia. 37, 10, p. 2129-2132 4 p.Research output: Contribution to journal › Comment/debate › Research › peer-review
- Published
Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study
Gisslinger, H., Klade, C., Georgiev, P., Krochmalczyk, D., Gercheva-Kyuchukova, L., Egyed, M., Rossiev, V., Dulicek, P., Illes, A., Pylypenko, H., Sivcheva, L., Mayer, J., Yablokova, V., Krejcy, K., Grohmann-Izay, B., Hasselbalch, H. C., Kralovics, R., Kiladjian, J. J., Bauer, F., Berbec, N. & 41 others, , 2020, In: The Lancet Haematology. 7, 3, p. e196-e208 13 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Ropeginterferon Alfa-2b: Efficacy and Safety in Different Age Groups
Gisslinger, H., Klade, C., Georgiev, P., Krochmalczyk, D., Gercheva-kyuchukova, L., Egyed, M., Rossiev, V., Dulicek, P., Illes, A., Pylypenko, H., Sivcheva, L., Mayer, J., Yablokova, V., Krejcy, K., Hasselbalch, Hans Carl, Kralovics, R. & Kiladjian, J., 2020, In: HemaSphere. 4, 6, 4 p., e485.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Serum levels of IL-4, IL-13 and IL-33 in patients with age-related macular degeneration and myeloproliferative neoplasms
Gotfredsen, K., Liisborg, C., Skov, V., Kjær, L., Hasselbalch, Hans Carl & Sørensen, Torben Lykke, 11 Mar 2023, In: Scientific Reports. 13, 1, p. 4077 7 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
An arginase1- and PD-L1-derived peptide-based vaccine for myeloproliferative neoplasms: A first-in-man clinical trial
Grauslund, J. H., Holmström, M. O., Martinenaite, E., Lisle, T. L., Glöckner, H. J., Fassi, Daniel El , Klausen, U., Mortensen, R. E. J., Jørgensen, N., Kjær, L., Skov, V., Svane, Inge Marie, Hasselbalch, Hans Carl & Andersen, Mads Hald, 2023, In: Frontiers in Immunology. 14, 14 p., 1117466.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Classification and Personalized Prognosis in Myeloproliferative Neoplasms
Grinfeld, J., Nangalia, J., Baxter, E. J., Wedge, D. C., Angelopoulos, N., Cantrill, R., Godfrey, A. L., Papaemmanuil, E., Gundem, G., MacLean, C., Cook, J., O'Neil, L., O'Meara, S., Teague, J. W., Butler, A. P., Massie, C. E., Williams, N., Nice, F. L., Andersen, C. L., Hasselbalch, H. C. & 7 others, , 2018, In: The New England Journal of Medicine. 379, 15, p. 1416-1430Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Thrombopoietin-receptor agonists in haematological disorders: The Danish experience
Gudbrandsdottir, S., Hasselbalch, Hans Carl & Frederiksen, H., 1 Sep 2012, In: Platelets. 23, 6, p. 423-429 7 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Effects of rituximab and dexamethasone on regulatory and proinflammatory B-cell subsets in patients with primary immune thrombocytopenia
Gudbrandsdottir, S., Brimnes, M., Køllgaard, T., Hasselbalch, Hans Carl & Nielsen, C. H., 2018, In: European Journal of Haematology. 100, 1, p. 45-52Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Safety and efficacy of the combination of sonidegib and ruxolitinib in myelofibrosis: A phase 1b/2 dose-finding study
Gupta, V., Wolleschak, D., Hasselbalch, Hans Carl, Vannucchi, A. M., Koschmieder, S., Cervantes, F., Li, Y., Dong, T., Wroclawska, M., Bharathy, S. & Harrison, C., 2020, In: Blood advances. 4, 13, p. 3063-3071 9 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Therapeutic Cancer Vaccination With a Peptide Derived From the Calreticulin Exon 9 Mutations Induces Strong Cellular Immune Responses in Patients With CALR-Mutant Chronic Myeloproliferative Neoplasms
Handlos Grauslund, J., Holmström, M. O., Jørgensen, N. G., Klausen, U., Weis-Banke, S. E., El Fassi, D., Schöllkopf, C., Clausen, M. B., Gjerdrum, L. M. R., Breinholt, M. F., Kjeldsen, J. W., Hansen, M., Koschmieder, S., Chatain, N., Novotny, G. W., Petersen, J., Kjær, L., Skov, V., Met, Ö., Svane, I. M. & 2 others, , 26 Feb 2021, In: Frontiers in Oncology. 11, 17 p., 637420.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Second malignancies in hydroxyurea and interferon-treated Philadelphia-negative myeloproliferative neoplasms
Hansen, I. O., Sørensen, A. L. & Hasselbalch, Hans Carl, 2017, In: European Journal of Haematology. 98, 1, p. 75-84Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Anemia is present years before myelodysplastic syndrome diagnosis: Results from the pre-diagnostic period
Hansen, Jakob Werner, Sandholdt, H., Siersma, Volkert Dirk, mxz703, mxz703, Holmberg, S., Bjerrum, O. W., Hasselbalch, Hans Carl, Olivarius, Niels de Fine, Grønbæk, Kirsten & Andersen, Christen Bertel L, Jul 2017, In: American Journal of Hematology. 92, 7, p. E130-E132 3 p.Research output: Contribution to journal › Comment/debate › Research › peer-review
ID: 2849472
Most downloads
-
159
downloads
A nationwide population-based cross-sectional survey of health-related quality of life in patients with myeloproliferative neoplasms in Denmark (MPNhealthSurvey): survey design and characteristics of respondents and nonrespondents
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
154
downloads
Epigenetic changes in myelofibrosis: Distinct methylation changes in the myeloid compartments and in cases with ASXL1 mutations
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
137
downloads
Mathematical modelling as a proof of concept for MPNs as a human inflammation model for cancer development
Research output: Contribution to journal › Journal article › Research › peer-review
Published